New York Life Investment Management »

Bridgebio Pharma shares owned by New York Life Investment Management

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by New York Life Investment Management from 13F filings

Historical chart of New York Life Investment Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by New York Life Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by New York Life Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $847k 21k 40.37
2023-09-30 $565k 21k 26.37
2023-06-30 $428k 25k 17.20
2023-03-31 $446k 27k 16.58

More positions owned by New York Life Investment Management

Apple (AAPL)
Microsoft Corporation (MSFT)
Indexiq Etf Tr Candriam Us Larg (IQSU)
Indexiq Active Etf Tr Iq Mackay Esg Cr (ESGB)
Amazon (AMZN)
Indexiq Etf Tr Candriam Us Mid (IQSM)
NVIDIA Corporation (NVDA)
Indexiq Etf Tr Candriam Interna (IQSI)
Indexiq Etf Tr Iq 500 Int Etf (IQIN)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Indexiq Etf Tr Iq U.s. Small Ca (CSML)
Indexiq Etf Tr Iq Cbre Nexgen (ROOF)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Indexiq Etf Tr Ftse Internl Eqt (HFXI)

View all positions for New York Life Investment Management

Top funds holding Bridgebio Pharma

Kohlberg Kravis Roberts & Co
Viking Global Investors
Vanguard Group
Aisling Capital Management
Laurion Capital Management
Cormorant Asset Management
Goldman Sachs Group
Lord, Abbett & Co
Frazier Life Sciences Management
Alliancebernstein
Perceptive Advisors
Citigroup
Wellington Management Company
Hillhouse Capital Advisors
Norges Bank Investment Management

View all funds holding Bridgebio Pharma